[1] POWERS W J，RABINSTEIN A A，ACKERSON

T，et al. 2018 guidelines for the early management of

patients with acute ischemic stroke：a guideline for

healthcare professionals from the American Heart

Association/American Stroke Association[J/OL].

Stroke，2018，49（3）：e46-e110[2019-12-11].

https：//doi.org/10.1161/STR.0000000000000158.

[2] 中国老年医学学会急诊医学分会，中华医学会急诊

医学分会卒中学组，中国卒中学会急救医学分会. 急性缺血性脑卒中急诊急救中国专家共识2018[J]. 中

国卒中杂志，2018，13（9）：956-967.

[3] 王陇德，刘建民，杨弋，等. 我国脑卒中防治仍面临

巨大挑战——《中国脑卒中防治报告2018》概要[J].

中国循环杂志，2019，34（2）：105-119.

[4] EMBERSON J，LEES K R，LYDEN P，et al. Effect

of treatment delay，age，and stroke severity on the

effects of intravenous thrombolysis with alteplase for

acute ischaemic stroke：a meta-analysis of individual

patient data from randomised trials[J]. Lancet，2014，

384（9958）：1929-1935.

[5] ALI M，FULTON R，QUINN T，et al. How well do

standard stroke outcome measures reflect quality of

life? A retrospective analysis of clinical trial data[J].

Stroke，2013，44（11）：3161-3165.

[6] 国家卫生计生委办公厅，国家中医药管理局办公室.

国家卫生计生委办公厅国家中医药管理局办公室

关于印发脑卒中综合防治工作方案的通知[R/OL].

（2016-12-09）[2019-12-11]. http：//www.nhc.gov.cn/

jkj/s5879/201612/cef09e0c26744df38fa710d3c0da75c

e.shtml.

[7] KIDWELL C S，SAVER J L，CARNEADO J，et al.

Predictors of hemorrhagic transformation in patients

receiving intra-arterial thrombolysis[J]. Stroke，2002，

33（3）：717-724.

[8] KHATRI P，KLEINDORFER D O，DEVLIN T，

et al. Effect of Alteplase vs aspirin on functional

outcome for patients with acute ischemic stroke and

minor nondisabling neurologic deficits：the PRISMS

randomized clinical trial[J]. JAMA，2018，320（2）：

156-166.

[9] WHITELEY W N，EMBERSON J，LEES K R，et

al. Risk of intracerebral haemorrhage with alteplase

after acute ischaemic stroke：a secondary analysis of

an individual patient data meta-analysis[J]. Lancet

Neurol，2016，15（9）：925-933.

[10] LEES K R，BLUHMKI E，VON KUMMER R，et

al. Time to treatment with intravenous alteplase

and outcome in stroke：an updated pooled analysis

of ECASS，ATLANTIS，NINDS，and EPITHET

trials[J]. Lancet，2010，375（9727）：1695-1703.

[11] KHATRI P，ABRUZZO T，YEATTS S D，et al.

Good clinical outcome after ischemic stroke with

successful revascularization is time-dependent[J].

Neurology，2009，73（13）：1066-1072.

[12] MA H，CAMPBELL B C V，PARSONS M W，et

al. Thrombolysis guided by perfusion imaging up to

9 hours after onset of stroke[J]. N Engl J Med，2019，

380（19）：1795-1803.

[13] PANTONI L，FIERINI F，POGGESI A.

Thrombolysis in acute stroke patients with cerebral

small vessel disease[J]. Cerebrovasc Dis，2014，37

（1）：5-13.

[14] KONGBUNKIAT K，WILSON D，KASEMSAP

N，et al. Leukoaraiosis，intracerebral hemorrhage，

and functional outcome after acute stroke

thrombolysis[J]. Neurology，2017，88（7）：638-645.

[15] IST-3 collaborative group. Association between

brain imaging signs，early and late outcomes，and

response to intravenous alteplase after acute

ischaemic stroke in the third International Stroke

Trial（IST-3）：secondary analysis of a randomised

controlled trial[J]. Lancet Neurol，2015，14（5）：

485-496.

[16] CHARIDIMOU A，SHOAMANESH A. Clinical

relevance of microbleeds in acute stroke thrombolysis：

comprehensive meta-analysis[J]. Neurology，2016，87

（15）：1534-1541.

[17] LIU X Y，LI T，DIAO S S，et al. The global

burden of cerebral small vessel disease related to

neurological deficit severity and clinical outcomes

of acute ischemic stroke after IV rt-PA treatment[J].

Neurol Sci，2019，40（6）：1157-1166.

[18] POWERS W J，RABINSTEIN A A，ACKERSON

T，et al. Guidelines for the early management of

patients with acute ischemic stroke：2019 update

to the 2018 guidelines for the early management of

acute ischemic stroke：a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J/OL]. Stroke，2019，

50（12）：e344-e418[2019-12-11]. https：//doi.

org/10.1161/STR.0000000000000211.

[19] LIN S F，CHAO A C，HU H H，et al. Hyperglycemia

predicts unfavorable outcomes in acute ischemic

stroke patients treated with intravenous thrombolysis

among a Chinese population：a prospective cohort

study[J/OL]. J Neurol Sci，2018，388：195-202[2019-

12-11]. https：//doi.org/10.1016/j.jns.2018.03.022.

[20] OSEI E，FONVILLE S，ZANDBERGEN A，et

al. Impaired fasting glucose is associated with

unfavorable outcome in ischemic stroke patients

treated with intravenous alteplase[J]. J Neurol，2018，

265（6）：1426-1431.

[21] UCHIMURA I，KAIBARA M，NAGASAWA

M，et al. Effect of circulating tissue factor on

hypercoagulability in type 2 diabetes mellitus

studied by rheometry and dielectric blood

coagulometry[J]. Biorheology，2016，53（5/6）：209-

219.

[22] CAPES S E，HUNT D，MALMBERG K，et al.

Stress hyperglycemia and prognosis of stroke in

nondiabetic and diabetic patients：a systematic

overview[J]. Stroke，2001，32（10）：2426-2432.

[23] BOSHUIZEN M，STEINBERG G K. Stem Cell

-based immunomodulation after stroke：effects on

brain repair processes[J]. Stroke，2018，49（6）：

1563-1570.

[24] PEREZ-DE-PUIG I，MIRO-MUR F，FERRERFERRER

M，et al. Neutrophil recruitment to the

brain in mouse and human ischemic stroke[J]. Acta

Neuropathol，2015，129（2）：239-257.

[25] LIU H H，WANG R J，SHI J J，et al. Baseline

neutrophil counts and neutrophil ratio may predict

a poor clinical outcome in minor stroke patients

with intravenous thrombolysis[J/OL]. J Stroke

Cerebrovasc Dis，2019，28（11）：104340[2019-12-

11]. https：//doi.org/10.1016/j.jstrokecerebrovasd

is.2019.104340.

[26] MAESTRINI I，STRBIAN D，GAUTIER S，et

al. Higher neutrophil counts before thrombolysis

for cerebral ischemia predict worse outcomes[J].

Neurology，2015，85（16）：1408-1416.

[27] GENSICKE H，AL SULTAN A S，STRBIAN D，et

al. Intravenous thrombolysis and platelet count[J/OL].

Neurology，2018，90（8）：e690-e697[2019-12-11].

https：//doi.org/10.1212/WNL.0000000000004982.

[28] KANNAN M，AHMAD F，SAXENA R. Platelet

activation markers in evaluation of thrombotic risk

factors in various clinical settings[J/OL]. Blood

Rev，2019，37：100583[2019-12-11]. https：//doi.

org/10.1016/j.blre.2019.05.007.

[29] STASZEWSKI J，POGODA A，DATA K，et al.

The mean platelet volume on admission predicts

unfavorable stroke outcomes in patients treated with

IV thrombolysis[J/OL]. Clin Interv Aging，2019，14：

493-503[2019-12-11]. https：//doi.org/10.2147/CIA.

S195451.

[30] CHEN S Y，LIN Y S，CHENG Y F，et al. Mean

platelet volume-to-lymphocyte ratio predicts poor

functional outcomes among ischemic stroke patients

treated with intravenous thrombolysis[J/OL]. Front

Neurol，2019，10：1274[2019-12-11]. https：//doi.

org/10.3389/fneur.2019.01274.

[31] DALKARA T，ARSAVA E M. Can restoring

incomplete microcirculatory reperfusion improve

stroke outcome after thrombolysis?[J]. J Cereb Blood

Flow Metab，2012，32（12）：2091-2099.

[32] KRAUSE G S，WHITE B C，AUST S D，et al. Brain

cell death following ischemia and reperfusion：a

proposed biochemical sequence[J]. Crit Care Med，

1988，16（7）：714-726.

[33] SIESJO B K. Pathophysiology and treatment of focal

cerebral ischemia. Part I：pathophysiology[J]. J

Neurosurg，1992，77（2）：169-184.

[34] WANG X Y，LO E H. Triggers and mediators of

hemorrhagic transformation in cerebral ischemia[J].

Mol Neurobiol，2003，28（3）：229-244.

[35] SUN M S，JIN H，SUN X，et al. Free radical

damage in ischemia-reperfusion injury：an obstacle

in acute ischemic stroke after revascularization

therapy[J/OL]. Oxid Med Cell Longev，2018，

2018：3804979[2019-12-11]. https：//doi.

org/10.1155/2018/3804979.

[36] SEET R C，RABINSTEIN A A. Symptomatic

intracranial hemorrhage following intravenous

thrombolysis for acute ischemic stroke：a critical

review of case definitions[J]. Cerebrovasc Dis，2012，

34（2）：106-114.

[37] YAGHI S，WILLEY J Z，CUCCHIARA B，et

al. Treatment and outcome of hemorrhagic

transformation after intravenous alteplase in acute

ischemic stroke：a scientific statement for healthcare

professionals from the American Heart Association/

American Stroke Association[J/OL]. Stroke，2017，48

（12）：e343-e361[2019-12-11]. https：//doi.org/10.1161/

STR.0000000000000152.

[38] LEES K R，BLUHMKI E，VON KUMMER R，et

al. Time to treatment with intravenous alteplase

and outcome in stroke：an updated pooled analysis

of ECASS，ATLANTIS，NINDS，and EPITHET

trials[J]. Lancet，2010，375（9727）：1695-1703.

[39] YAGHI S，BOEHME A K，DIBU J，et al. Treatment

and outcome of thrombolysis-related hemorrhage：a

multicenter retrospective study[J]. JAMA Neurol，

2015，72（12）：1451-1457.

[40] STRBIAN D，SAIRANEN T，MERETOJA A，et

al. Patient outcomes from symptomatic intracerebral

hemorrhage after stroke thrombolysis[J]. Neurology，

2011，77（4）：341-348.

[41] 王茂湘，王晓东，范铁平，等. 急性缺血性脑卒中患

者静脉溶栓后出血转化与预后分析[J]. 当代医学，

2018，24（21）：144-145.

[42] 李弘，石秋艳，张春阳，等. 血糖及血糖变异性对急

性缺血性脑卒中静脉溶栓预后的影响[J]. 中华老年

心脑血管病杂志，2016，18（5）：518-521.

[43] SHI J，PENG H，YOU S，et al. Increase in

neutrophils after recombinant tissue plasminogen

activator thrombolysis predicts poor functional

outcome of ischaemic stroke：a longitudinal study[J].

Eur J Neurol，2018，25（4）：645-687.

[44] STRBIAN D，MICHEL P，SEIFFGE D J，et al.

Symptomatic intracranial hemorrhage after stroke

thrombolysis：comparison of prediction scores[J].

Stroke，2014，45（3）：752-758.

[45] SUNG S F，CHEN S C，LIN H J，et al. Comparison

of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous

thrombolysis[J]. Stroke，2013，44（6）：1561-1566.

[46] LI M，WANG-QIN R Q，WANG Y L，et al.

Symptomatic intracerebral hemorrhage after

intravenous thrombolysis in Chinese patients：

comparison of prediction models[J]. J Stroke

Cerebrovasc Dis，2015，24（6）：1235-1243.

[47] BARBER P A，DEMCHUK A M，ZHANG

J，et al. Validity and reliability of a quantitative

computed tomography score in predicting outcome

of hyperacute stroke before thrombolytic therapy.

ASPECTS Study Group. Alberta Stroke Programme

Early CT Score[J]. Lancet，2000，355（9216）：1670-

1674.

[48] KENT D M，SELKER H P，RUTHAZER R，et al.

The stroke-thrombolytic predictive instrument：a

predictive instrument for intravenous thrombolysis

in acute ischemic stroke[J]. Stroke，2006，37（12）：

2957-2962.

[49] STRBIAN D，MERETOJA A，AHLHELM F J，et

al. Predicting outcome of IV thrombolysis-treated

ischemic stroke patients：the DRAGON score[J].

Neurology，2012，78（6）：427-432.

[50] SAPOSNIK G，FANG J，KAPRAL M K，et al. The

iScore predicts effectiveness of thrombolytic therapy

for acute ischemic stroke[J]. Stroke，2012，43（5）：

1315-1322.

[51] FLINT A C，FAIGELES B S，CULLEN S P，et al.

THRIVE score predicts ischemic stroke outcomes

and thrombolytic hemorrhage risk in VISTA[J].

Stroke，2013，44（12）：3365-3369.

[52] FLINT A C，CULLEN S P，FAIGELES B S，et al.

Predicting long-term outcome after endovascular

stroke treatment：the totaled health risks in vascular

events score[J]. AJNR Am J Neuroradiol，2010，31

（7）：1192-1196.

[53] SEIFFGE D J，KARAGIANNIS A，STRBIAN D，et

al. Simple variables predict miserable outcome after

intravenous thrombolysis[J]. Eur J Neurol，2014，21

（2）：185-191.

[54] CAPPELLARI M，TURCATO G，FORLIVESI

S，et al. The START nomogram for individualized

prediction of the probability of unfavorable outcome

after intravenous thrombolysis for stroke[J]. Int J

Stroke，2018，13（7）：700-706.

[55] SONG B L，CHEN X L，TANG D，et al. External

Validation of START nomogram to predict 3-Month

unfavorable outcome in Chinese acute stroke

patients[J]. J Stroke Cerebrovasc Dis，2019，28（6）：

1618-1622.